Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells

Acquired resistance to targeted inhibitors remains a major, and inevitable, obstacle in the treatment of oncogene-addicted cancers. Newer-generation inhibitors may help overcome resistance mutations, and inhibitor combinations can target parallel pathways, but durable benefit to patients remains elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Amit Dipak, Rajan, Soumya S., Groysman, Matthew J., Pongtornpipat, Praechompoo, Schatz, Jonathan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681422/
https://www.ncbi.nlm.nih.gov/pubmed/26688666
http://dx.doi.org/10.4137/BIC.S29326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681422/
https://www.ncbi.nlm.nih.gov/pubmed/26688666
http://dx.doi.org/10.4137/BIC.S29326

Ejemplares similares